Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unithiol Phase I
PACTR202103718625048Phase 1Recruiting
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 2,3-Dimercapto-1-propanesulfonic acid in Intoxication, sponsored by Liverpool School of Tropical Medicine. Primary endpoint: Safety and tolerability. Started Sep 2021; status: recruiting.
02
Drugs
2,3-Dimercapto-1-propanesulfonic acid
03
Conditions
Intoxication
Beyond the preview
Go deeper on PACTR202103718625048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202103718625048.